ΔNp63 regulates IL-33 and IL-31 signaling in atopic dermatitis

Cell Death and Differentiation

Volumn 23, Issue 6, 2016, Pages 1073-1085

  Rizzo, J M ^a   Oyelakin, A ^b   Min, S ^b   Smalley, K ^a   Bard, J ^a   Luo, W ^a,e   Nyquist, J ^a   Guttman Yassky, E ^c   Yoshida, T ^d   De Benedetto, A ^d   Beck, L A ^d   Sinha, S ^a   Romano, R A ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 31; INTERLEUKIN 33; PROTEIN P63; CYTOKINE; IL31RA PROTEIN, MOUSE; IMMUNOGLOBULIN E; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-31, MOUSE; ONCOSTATIN M RECEPTOR; PHOSPHOPROTEIN; PROTEIN BINDING; TRANSACTIVATOR PROTEIN; TRP63 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; EPIDERMIS; EPIDERMIS HYPERPLASIA; GENE TARGETING; HUMAN; IMMUNOREGULATION; INTRACELLULAR SIGNALING; KERATINOCYTE; MOUSE; NONHUMAN; PATIENT; PHENOTYPE; PRIORITY JOURNAL; PRURITUS; SIGNAL TRANSDUCTION; TH2 CELL; ANIMAL; BLOOD; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN; TRANSGENIC MOUSE;

ANIMALS; CYTOKINES; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-33; INTERLEUKINS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PHENOTYPE; PHOSPHOPROTEINS; PROTEIN BINDING; RECEPTORS, INTERLEUKIN; RECEPTORS, ONCOSTATIN M; SIGNAL TRANSDUCTION; SKIN; TH2 CELLS; TRANS-ACTIVATORS;

EID: 84954438899     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.162     Document Type: Article

References (68)

1. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-160
3. Bieber T. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494
4. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246
5. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 1315-1327
6. Savinko T, Matikainen S, Saarialho-Kere U, Lehto M, Wang G, Lehtimaki S., et al. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132: 1392-1400
7. Imai Y, Yasuda K, Sakaguchi Y, Haneda T, Mizutani H, Yoshimoto T., et al. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci USA 2013; 110: 13921-13926
8. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X., et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013; 210: 2939-2950
9. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001; 117: 977-983
10. Zheng T, Oh MH, Oh SY, Schroeder JT, Glick AB, Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 2009; 129: 742-751
11. Zhu Z, Oh MH, Yu J, Liu YJ, Zheng T. The Role of TSLP in IL-13-induced atopic march. Sci Rep 2011; 1: 23
12. Pignon JC, Grisanzio C, Geng Y, Song J, Shivdasani RA, Signoretti S. p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci USA 2013; 110: 8105-8110
13. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT., et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999; 398: 714-718
14. Mills AA, Zheng B,Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713
15. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S., et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 2001; 98: 3156-3161
16. Senoo M, Pinto F, Crum CP, McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129: 523-536
17. Romano RA, Smalley K, Liu S, Sinha S. Abnormal hair follicle development and altered cell fate of follicular keratinocytes in transgenic mice expressing DeltaNp63alpha. Development 2010; 137: 1431-1439
18. Van Bokhoven H, McKeon F. Mutations in the p53 homolog p63: allele-specific developmental syndromes in humans. Trends Mol Med 2002; 8: 133-139
19. Ha L, Ponnamperuma RM, Jay S, Ricci MS, Weinberg WC. Dysregulated DeltaNp63alpha inhibits expression of Ink4a/arf, blocks senescence, and promotes malignant conversion of keratinocytes. PLoS One 2011; 6: e21877
20. Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J., et al. DeltaNp63 versatilely regulates a Broad NF-kappaB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Cancer Res 2011; 71: 3688-3700
21. Lu H, Yang X, Duggal P, Allen CT, Yan B, Cohen J., et al. TNF-Alpha promotes c-REL/ DeltaNp63alpha interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. Cancer Res 2011; 71: 6867-6877
22. Gu X, Lundqvist EN, Coates PJ, Thurfjell N, Wettersand E, Nylander K. Dysregulation of TAp63 mRNA and protein levels in psoriasis. J Invest Dermatol 2006; 126: 137-141
23. Shen CS, Tsuda T, Fushiki S, Mizutani H, Yamanishi K. The expression of p63 during epidermal remodeling in psoriasis. J Dermatol 2005; 32: 236-242
24. Kim SY, Cho HJ, Kim DS, Choi HR, Kwon SB, Na JI., et al. Differential expression of p63 isoforms in normal skin and hyperproliferative conditions. J Cutan Pathol 2009; 36: 825-830
25. Romano RA, Smalley K, Magraw C, Serna VA, Kurita T, Raghavan S., et al. {Delta}Np63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation. Development 2012; 139: 772-782
26. Rizzo JM, Romano RA, Bard J, Sinha S. RNA-seq studies reveal new insights into p63 and the transcriptomic landscape of the mouse skin. J Invest Dermatol 2014; 135: 629-632
27. Shalom-Feuerstein R, Lena AM, Zhou H, De La Forest Divonne S, Van Bokhoven H, Candi E., et al. DeltaNp63 is an ectodermal gatekeeper of epidermal morphogenesis. Cell Death Differ 2011; 18: 887-896
28. Chakravarti D, Su X, Cho MS, Bui NH, Coarfa C, Venkatanarayan A., et al. Induced multipotency in adult keratinocytes through down-regulation of DeltaNp63 or DGCR8. Proc Natl Acad Sci USA 2014; 111: E572-E581
29. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004; 5: 752-760
30. Romano RA, Ortt K, Birkaya B, Smalley K, Sinha S. An active role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14 and directing epidermal cell fate. PLoS One 2009; 4: e5623
31. Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int 2013; 62: 151-161
32. Tokura Y. Extrinsic and intrinsic types of atopic dermatitis. J Dermatol Sci 2010; 58: 1-7
33. Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A, Nograles KE, Shemer A, Fuentes-Duculan J., et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009; 124: 1235-44 e58
34. Suarez-Farinas M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I., et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 2011; 127: 954-964, e1-4
35. Kuo IH, Carpenter-Mendini A, Yoshida T, McGirt LY, Ivanov AI, Barnes KC., et al. Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair. J Invest Dermatol 2013; 133: 988-998
36. Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest 2003; 112: 1058-1066
37. Gharagozlou M, Farhadi E, Khaledi M, Behniafard N, Sotoudeh S, Salari R., et al. Association between the interleukin 6 genotype at position -174 and atopic dermatitis. J Investig Allergol Clin Immunol 2013; 23: 89-93
38. Koren Carmi I, Haj R, Yehuda H, Tamir S, Reznick AZ. The role of oxidation in FSL-1 induced signaling pathways of an atopic dermatitis model in HaCaT keratinocytes. Adv Exp Med Biol 2015; 849: 1-10
39. Brandt EB, Sivaprasad U. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2011; 2: 3
40. Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H. Role of interleukin-33 in innatetype immune cells in allergy. Allergol Int 2013; 62: 13-20
41. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, Gronhoj-Larsen C., et al. Anti-interleukin-31-Antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009; 18: 35-43
42. Szegedi K, Kremer AE, Kezic S, Teunissen MB, Bos JD, Luiten RM., et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol 2012; 21: 431-436
43. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L., et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006; 117: 418-425
44. Consortium EP. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011; 9: e1001046
45. Kouwenhoven EN, Van Heeringen SJ, Tena JJ, Oti M, Dutilh BE, Alonso ME., et al. Genome-wide profiling of p63 DNA-binding sites identifies an element that regulates gene expression during limb development in the 7q21 SHFM1 locus. PLoS Genet 2010; 6: e1001065
46. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE,Wang Z., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129: 823-837
47. Bernstein BE, Kamal M, Lindblad-Toh K, Bekiranov S, Bailey DK, Huebert DJ., et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 2005; 120: 169-181
48. Consortium EP, Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007; 447: 799-816
49. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007; 39: 311-318
50. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459: 108-112
51. Romano RA, Birkaya B, Sinha S. A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J Invest Dermatol 2007; 127: 1175-1186
52. Du J, Romano RA, Si H, Mattox A, Bian Y, Yang X., et al. Epidermal overexpression of transgenic DeltaNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-kappaB activation. J Pathol 2014; 232: 356-368
53. Cornelissen C, Marquardt Y, Czaja K, Wenzel J, Frank J, Luscher-Firzlaff J., et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol 2012; 129: 426-433, 33, e1-8
54. Stott B, Lavender P, Lehmann S, Pennino D, Durham S, Schmidt-Weber CB. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol 2013; 132: 446-454, e5
55. Kubo T, Kamekura R, Kumagai A, Kawata K, Yamashita K, Mitsuhashi Y., et al. DeltaNp63 controls a TLR3-mediated mechanism that abundantly provides thymic stromal lymphopoietin in atopic dermatitis. PLoS One 2014; 9: e105498
56. Kubo T, Sugimoto K, Kojima T, Sawada N, Sato N, Ichimiya S. Tight junction protein claudin-4 is modulated via DeltaNp63 in human keratinocytes. Biochem Biophys Res Commun 2014; 455: 205-211
57. Diamond I, Owolabi T, Marco M, Lam C, Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 2000; 115: 788-794
58. Romano RA, Birkaya B, Sinha S. Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: Potential roles for Sp1/Sp3, NF-Y, and p63. J Invest Dermatol 2006; 126: 1469-1479
59. Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH., et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 1990; 85: 927-933
60. Akei HS, Brandt EB, Mishra A, Strait RT, Finkelman FD, Warrier MR., et al. Epicutaneous aeroallergen exposure induces systemic TH2 immunity that predisposes to allergic nasal responses. J Allergy Clin Immunol 2006; 118: 62-69
61. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9: 461-466
62. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996; 70: 5701-5705
63. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR., et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-578
64. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 2013; 31: 46-53
65. Saldanha AJ. Java Treeview-extensible visualization of microarray data. Bioinformatics 2004; 20: 3246-3248
66. Eichenfield LF. Consensus guidelines in diagnosis and treatment of atopic dermatitis. Allergy 2004; 59(Suppl 78): 86-92
67. Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74
68. Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T., et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature 2014; 515: 355-364